Success Metrics

Clinical Success Rate
82.1%

Based on 64 completed trials

Completion Rate
82%(64/78)
Active Trials
16(11%)
Results Posted
27%(17 trials)
Terminated
14(10%)

Phase Distribution

Ph early_phase_1
2
1%
Ph phase_1
12
8%
Ph phase_2
34
23%
Ph phase_4
16
11%
Ph not_applicable
52
36%
Ph phase_3
20
14%

Phase Distribution

14

Early Stage

34

Mid Stage

36

Late Stage

Phase Distribution136 total trials
Early Phase 1First-in-human
2(1.5%)
Phase 1Safety & dosage
12(8.8%)
Phase 2Efficacy & side effects
34(25.0%)
Phase 3Large-scale testing
20(14.7%)
Phase 4Post-market surveillance
16(11.8%)
N/ANon-phased studies
52(38.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

73.6%

64 of 87 finished

Non-Completion Rate

26.4%

23 ended early

Currently Active

16

trials recruiting

Total Trials

145

all time

Status Distribution
Active(23)
Completed(64)
Terminated(23)
Other(35)

Detailed Status

Completed64
unknown35
Terminated14
Recruiting12
Withdrawn9
Not yet recruiting6

Development Timeline

Analytics

Development Status

Total Trials
145
Active
16
Success Rate
82.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.5%)
Phase 112 (8.8%)
Phase 234 (25.0%)
Phase 320 (14.7%)
Phase 416 (11.8%)
N/A52 (38.2%)

Trials by Status

terminated1410%
enrolling_by_invitation11%
unknown3524%
active_not_recruiting43%
completed6444%
recruiting128%
not_yet_recruiting64%
withdrawn96%

Recent Activity

Clinical Trials (145)

Showing 20 of 145 trialsScroll for more
NCT01042379Phase 2

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Recruiting
NCT06297096Phase 3

Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease

Recruiting
NCT06950294Early Phase 1

iNO300 Therapy in Critically Ill Patients With Pneumonia

Recruiting
NCT04314687Phase 1

Stem Cell and Conditioned Medium for Cerebral Palsy

Active Not Recruiting
NCT07214818Phase 2

SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome

Active Not Recruiting
NCT07349836Early Phase 1

Application of mRNA Immunotherapy Technology in EB Virus Related Diseases

Not Yet Recruiting
NCT07342088Not Applicable

Lactobacillus Acidophilus and Limosilactobacillus Reuteri for Acute Diarrhea in Children

Completed
NCT07327710Not Applicable

Non-Invasive Brain-Computer Interface Combined With Transcranial Electrical Stimulation for Peripheral Facial PalsyStimulation in the Treatment of Peripheral Facial Palsy

Enrolling By Invitation
NCT00929214Phase 2

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Active Not Recruiting
NCT07242222Phase 1

Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease

Recruiting
NCT07238985Phase 1

Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease

Recruiting
NCT06008587Not Applicable

Contribution of Nasal High Flow in Pneumology Assessed in Acid-Free Hypercapnic Acute Respiratory Failure

Terminated
NCT06924710Not Applicable

Adaptive Therapy for Resected Stage ⅠA2-Ⅱ NSCLC Patients With Undetectable MRD

Recruiting
NCT03075423Phase 2

Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC

Completed
NCT07150663Phase 3

Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer

Recruiting
NCT04908865Phase 4

Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)

Completed
NCT06808256Not Applicable

Effect of Acupuncture on Hemodynamics and Pain of Post Craniotomy Patients With Mechanical Ventilation

Completed
NCT07015450Phase 4

The Efficacy of Self-Manufactured 40% Dextrose Gel in Asymptomatic Transient Neonatal Hypoglycemia Treatment

Completed
NCT06961188Phase 3

Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis

Not Yet Recruiting
NCT06960122Not Applicable

Clinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
145